Postchemotherapy Retroperitoneal Lymph Node Dissection


Creative Commons License

ÇITAMAK B., AKDOĞAN B., ALTAN M., Ozen H.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, cilt.13, sa.3, ss.169-175, 2014 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 13 Sayı: 3
  • Basım Tarihi: 2014
  • Doi Numarası: 10.4274/uob.138
  • Dergi Adı: UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.169-175
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Post-chemotherapy retroperitoneal lymph node dissection contributes most important survival results to advanced testicular cancer, however it is one of the most challenging surgeries technically in Uro-oncology. Besides, it is critical not only for treatment but also for staging of testicular cancer. It diminishes the need for chemotherapy. Boundaries of resection (template) is always a debate; wide limits may cause better staging but high rates of retrograde ejaculation, modified templates may cause better quality of life but unresected metastasis in some patients. Minimally invasive approaches are reasonable for diagnosis, although inadequate when performed without chemotherapy for cure, so they should be performed in experienced centers only.